Article Text

Download PDFPDF

Bayes pulmonary embolism assisted diagnosis: a new expert system for clinical use
Free
  1. Davide Luciani1,
  2. Silvio Cavuto1,
  3. Luca Antiga2,
  4. Massimo Miniati3,
  5. Simona Monti3,
  6. Massimo Pistolesi4,
  7. Guido Bertolini5
  1. 1Unit of Clinical Knowledge Engineering, Laboratory of Clinical Epidemiology, “Mario Negri” Institute of Pharmacological Research, Clinical Centre for Rare Diseases Aldo e Cele Daccò, Ranica (Bergamo), Italy
  2. 2Laboratory of Biomedical Technologies, “Mario Negri” Institute of Pharmacological Research, Clinical Centre for Rare Diseases Aldo e Cele Daccò, Ranica (Bergamo), Italy
  3. 3Department of Clinical Physiology, Italian National Research Council, Pisa, Italy
  4. 4Department of Critical Care, University of Florence, Firenze, Italy
  5. 5Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche “Mario Negri”, Centro “Aldo e Cele Daccò”, Ranica (Bergamo), Italy
  1. Correspondence to:
 Dr G Bertolini
 GiViTI Coordinating Center—Istituto di Ricerche Farmacologiche “Mario Negri”, Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò, Ranica (Bergamo) 24020, Italy; bertolini{at}marionegri.it

Abstract

Background: The diagnosis of pulmonary embolism demands flexible decision models, both for the presence of clinical confounders and for the variability of local diagnostic resources. As Bayesian networks fully meet this requirement, Bayes Pulmonary embolism Assisted Diagnosis (BayPAD), a probabilistic expert systems focused on pulmonary embolism, was developed.

Methods: To quantitatively validate and improve BayPAD, the system was applied to 750 patients from a prospective study done in an Italian tertiary hospital where the true pulmonary embolism status was confirmed using pulmonary angiography or ruled out with a lung scan. The proportion of correct diagnoses made by BayPAD (accuracy) and the correctness of the pulmonary embolism probabilities predicted by the model (calibration) were calculated. The calibration was evaluated according to the Cox regression–calibration model.

Results: Before refining the model, accuracy was 88.6%. Once refined, accuracy was 97.2% and 98%, respectively, in the training and validation samples. According to Cox analysis, calibration was satisfactory, despite a tendency to exaggerate the effect of the findings on the probability of pulmonary embolism. The lack of some investigations (like Spiral computed tomographic scan and Lower limbs doppler ultrasounds) in the pool of available data often prevents BayPAD from reaching the diagnosis without invasive procedures.

Conclusions: BayPAD offers clinicians a flexible and accurate strategy to diagnose pulmonary embolism. Simple to use, the system performs case-based reasoning to optimise the use of resources available within a particular hospital. Bayesian networks are expected to have a prominent role in the clinical management of complex diagnostic problems in the near future.

  • BayPAD, Bayes Pulmonary embolism Assisted Diagnosis
  • PISA-PED, Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding: This study was partially supported by Sanofi-Aventis Italy.

  • Competing interests: None.

Linked Articles

  • Primary Survey
    Steve Goodacre